Sorry - There were no pages found that contain that search phrase.
 |
|
|
|
|
|
Treatment |
|
Location |
|
Last Updated |
|
|
|
Details |
|
A Phase II Open-Label, Multiple-Dose Study of Intracavitary Administered 131I-TM-601 in Adult Patients with Recurrent High-Grade Glioma |
|
Baltimore, MD USA |
|
06/28/2008 |
|
|
|
|
|
Details |
|
Phase I and II, Open-Label, Multi-Center Trials of Pazopanib in Combination with Lapatinib in Adult Patients with Relapsed Malignant Glioma |
|
Bethesda, MD USA |
|
04/15/2008 |
|
|
|
Details |
|
Phase I/II Studies of BAY 43-9006 (Sorafenib) in Combination With OSI-774 (Erlotinib), R115777 (Tipifarnib) or CCI-779 (Temsirolimus) in Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma |
|
Bethesda, MD USA |
|
04/15/2008 |
|
|
|
|
|
Details |
|
Phase II Single Arm Trial of VEGF Trap in Patients With Recurrent Temozolomide-Resistant Malignant Gliomas |
|
Bethesda, MD USA |
|
04/15/2008 |
|
|
|
Details |
|
A Phase I Study of Vorinostat [Suberoylanilide Hydroxamic Acid (SAHA)] in Combination with Temozolomide in Patients with Malignant Gliomas |
|
Bethesda, MD USA |
|
04/15/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Annapolis, MD USA |
|
04/11/2008 |
|
|
|
Details |
|
NABTC 04-01: Lapatinib in Treating Patients Who Are Undergoing Surgery for Recurrent Progressive Glioblastoma Multiforme or Gliosarcoma |
|
Bethesda, MD USA |
|
10/03/2007 |
|
|
|
|
|
Details |
|
A Pharmacokinetic and Pharmacogenomic Study of Patients With High-Grade Gliomas Receiving Daily Radiation Therapy and Temozolomide |
|
Baltimore, MD USA |
|
08/31/2007 |
|
|
|
Details |
|
A Phase 2 Study of O-Benzylguanine (O6-BG) and Temozolomide in Patients With Glioblastoma Progressing at Least 3 Months After Completion of Primary Treatment With Radiation Therapy and Temozolomide |
|
Bethesda, MD USA |
|
08/26/2007 |
|
|
|
|
|
Details |
|
A Phase II Trial of Erlotinib (OSI-774) and Sorafenib (BAY 43-9006) for Patients With Progression or Recurrent Glioblastoma Multiforme |
|
Baltimore, MD USA |
|
08/26/2007 |
|
|
|
Details |
|
A Phase I Trial of Enzastaurin (LY317615) in Combination With Carboplatin in Adults With Recurrent Gliomas |
|
Bethesda, MD USA |
|
08/26/2007 |
|
|
|
|
|
Details |
|
A Phase I/II Study of ATN-161 and Carboplatin in Adult Patients With Recurrent Intracranial Malignant Glioma |
|
Bethesda, MD USA |
|
08/26/2007 |
|
|
|
Details |
|
Determination of the In-Tumor-Concentration of Imatinib Mesylate (Gleevec) in Malignant Glioma After Oral Administration |
|
Baltimore, MD USA |
|
08/20/2007 |
|
|
|
|
|
Details |
|
A Phase I Trial of Enzastaurin (LY317615) in Patients With Recurrent Gliomas |
|
Bethesda, MD USA |
|
08/20/2007 |
|
|
|
Details |
|
Eligibility Screening Of Patients With Central Nervous System Tumors For The National Cancer Institute`s (NCI) Clinical Research Protocols |
|
Bethesda, MD USA |
|
08/20/2007 |
|
|
|
|
|
Details |
|
A Phase II Clinical Trial of the Histone Deacetylase Inhibitor Valproic Acid in Combination With Temodar and Radiation Therapy in Patients With High Grade Gliomas |
|
Bethesda, MD USA |
|
08/20/2007 |
|
|
|
Details |
|
A Phase II Trial of Bevacizumab (Avastin) and Irinotecan (CPT-11) for Patients With Recurrent High-Grade Gliomas Immediately Following Tumor Progression After Treatment With Bevacizumab Alone |
|
Bethesda, MD USA |
|
08/19/2007 |
|
|
|
|
|
Details |
|
A Phase I, Open Label Study of AT-101 (Gossypol) Plus Radiotherapy and Temozolomide and of AT-101 Plus Adjuvant Temozolomide for Patients With Newly-Diagnosed Glioblastoma Multiforme |
|
Baltimore, MD USA |
|
08/19/2007 |
|
|
|
Details |
|
A Phase 1 / 2 Dose Escalation Study of Locally-Administered OncoGel® in Subjects With Recurrent Glioma |
|
Baltimore, MD USA |
|
08/18/2007 |
|
|
|
|
|
Details |
|
A Phase II Trial of BEVACIZUMAB for Patients with Recurrent High-Grade Gliomas |
|
Bethesda, MD USA |
|
08/18/2007 |
|
|
|
Details |
|
Phase I/II Study of Intravenous Infusion of Tetra-o-Methyl Nordihydroguaiaretic Acid (EM-1421) in Subjects With Recurrent High Grade Glioma |
|
Baltimore, MD USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma
|
|
Baltimore, MD USA |
|
05/01/2007 |
|
|
|
Details |
|
Cilengitide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Baltimore, MD USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
Talampanel, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
|
|
Baltimore, MD USA |
|
04/29/2007 |
|
|
|
Details |
|
Phase II Study of Talampanel in Patients With Recurrent High-Grade Gliomas
|
|
Bethesda, MD USA |
|
04/29/2007 |
|
|
|
|
|
Details |
|
Phase II Trial of Talampanel in Conjunction With Radiation Therapy With Recurrent and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Baltimore, MD USA |
|
04/29/2007 |
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Baltimore, MD USA |
|
04/29/2007 |
|
|
|
|
|
Details |
|
A Feasibility Assessment and a Phase I/II Trial of MLN518 (Tandutinib) for Treatment of Patients with Recurrent Glioblastoma |
|
Baltimore, MD USA |
|
04/28/2007 |
|
|
|
Details |
|
Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) |
|
Baltimore, MD USA |
|
10/12/2006 |
|
|
|
|
|
Details |
|
Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors |
|
Bethesda, MD USA |
|
06/02/2006 |
|
|
|
Details |
|
A Phase I/II Trial of ZD6474 for Patients with Recurrent High-Grade and Progressive Low-Grade Gliomas |
|
Bethesda, MD USA |
|
05/29/2006 |
|
|
|
|
|
Details |
|
Phase II Study of Rituximab, Temozolomide, and Methylprednisolone in Patients With Recurrent Primary CNS Non-Hodgkin`s Lymphoma |
|
Bethesda, MD USA |
|
05/27/2006 |
|
|
|
Details |
|
Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors |
|
Bethesda, MD USA |
|
05/27/2006 |
|
|
|
|
|
Details |
|
A Phase II Trial of Tamoxifen and Bortezomib (Velcade) in Patients with Recurrent High-Grade Gliomas |
|
Bethesda, MD USA |
|
05/01/2006 |
|
|
|
Details |
|
Phase I/II Study of ZD6474(Zactima) in Patients With Recurrent High-Grade or Progressive Low-Grade Gliomas |
|
Bethesda, MD USA |
|
05/01/2006 |
|
|
|
|
|
Details |
|
A Phase I/II Trial of Depsipeptide (FK228) in Patients with High-Grade Gliomas |
|
Bethesda, MD USA |
|
05/01/2006 |
|
|
|
Details |
|
A Phase II Clinical Trial of the Histone Deacetylase Inhibitor Valproic Acid in Combination with Temodar and Radiation Therapy in Patients with High Grade Gliomas |
|
Bethesda, MD USA |
|
05/01/2006 |
|
|
|
|
|
Details |
|
Phase II Study of O6-Benzylguanine and Temozolomide (Temodar) in Pediatric Patients With Recurrent or Progressive High-Grade Gliomas or Brain Stem Tumors |
|
Bethesda, MD USA |
|
05/01/2006 |
|
|
|
Details |
|
Phase II Study of O6-Benzylguanine and Temozolomide (Temodar) in Pediatric Patients With Recurrent or Progressive High-Grade Gliomas or Brain Stem Tumors |
|
Bethesda, MD USA |
|
05/01/2006 |
|
|
|
|
|
Details |
|
Bevacizumab in Treating Patients With Recurrent Glioma |
|
Bethesda, MD USA |
|
04/30/2006 |
|
|
|
Details |
|
A Phase II Trial of 06-Benzylguanine and Temozolomide in Pediatric Patients with Recurrent or Progressive High-Grade Gliomas and Recurrent or Progressive Brainstem Tumors |
|
Bethesda, MD USA |
|
04/30/2006 |
|
|
|
|
|
Details |
|
A Phase I/II Trial of PEG-Interferon Alfa-2B (PEG-Intron)
for Plexiform Neurofibromas (NF1 patients) |
|
Bethesda, MD USA |
|
12/04/2005 |
|
|
|
Details |
|
Phase I Dose Escalation Study of Gliadel in Adults with Recurrent Malignant Gliomas |
|
Baltimore, MD USA |
|
12/03/2005 |
|
|
|
|
|
Details |
|
A Randomized Phase II Study of Peg-Interferon Alpha-2B (Peg-Intron) Alone or in Combination with Thalidomide in Adults with Recurrent High-Grade Gliomas |
|
Bethesda, MD USA |
|
11/27/2005 |
|
|
|
Details |
|
A Randomized Phase II Study of Peg-Interferon Alpha-2B (Peg-Intron) Alone or in Combination with Thalidomide in Adults with Recurrent High-Grade Gliomas |
|
Bethesda, MD USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Baltimore, MD USA |
|
11/27/2005 |
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Baltimore, MD USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Silver Spring, MD USA |
|
11/27/2005 |
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Baltimore, MD USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
A Phase I, Molecular Biology, and Phase II Study of Lapatinib (GW572016) in Pediatric Patients with Recurrent or Refractory Medulloblastoma, Malignant Glioma or Ependymoma
|
|
Bethesda, MD USA |
|
11/27/2005 |
|
|
|
Details |
|
Collection of Blood and Urine Samples in Patients Receiving Radiation Therapy for Glioblastoma Multiforme |
|
Bethesda, MD USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Temozolomide During and After Radiation Therapy in Treating Patients Who Have Undergone Previous Surgery and Placement of Gliadel Wafers for Newly Diagnosed Glioblastoma Multiforme |
|
Baltimore, MD USA |
|
11/27/2005 |
|
|
|
Details |
|
A Phase I Trial of CC-8490 for the Treatment of Patients with Recurrent/Refractory High-Grade Gliomas |
|
Bethesda, MD USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
A Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Pediatric Patients with Primary and Metastatic Brain Tumors
|
|
Bethesda, MD USA |
|
11/27/2005 |
|
|
|
Details |
|
A Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Pediatric Patients with Primary and Metastatic Brain Tumors
|
|
Bethesda, MD USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Tipifarnib and Radiation Therapy in Treating Young Patients with Brainstem Glioma |
|
Bethesda, MD USA |
|
11/27/2005 |
|
|
|
Details |
|
Arsenic Trioxide and Radiation Therapy in Treating Young Patients With Newly Diagnosed Gliomas (Brainstem glioma, glioblastoma multiforme, gliosarcoma, anaplastic astrocytoma)
|
|
Baltimore, MD USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Thalomid™ and Carboplatin for the Treatment of Pediatric Brain Stem Glioma |
|
Baltimore, MD USA |
|
11/26/2005 |
|
|
|
Details |
|
Topotecan to Treat Patients with Meningeal Cancers |
|
Bethesda, MD USA |
|
11/26/2005 |
|
|
|
|
|
Details |
|
A Phase II Study of Pegylated Interferon Alfa-2b (Peg-Intron`) in Children with Diffuse Pontine Gliomas |
|
Bethesda, MD USA |
|
11/26/2005 |
|
|
|
Details |
|
A Phase I Trial of CC-5013 (Lenalidomide) in Pediatric Patients with Recurrent or Refractory Primary CNS Tumors |
|
Bethesda, MD USA |
|
11/25/2005 |
|
|
|
|
|
Details |
|
A Phase I Trial of CC-5013 (Lenalidomide) in Pediatric Patients with Recurrent or Refractory Primary CNS Tumors |
|
Bethesda, MD USA |
|
11/25/2005 |
|
|
|
Details |
|
A Prospective National Study to Molecularly and Genetically Characterize Human Gliomas |
|
Bethesda, MD USA |
|
11/25/2005 |
|
|
|
|
|
Details |
|
A Pilot Trial of Low-Dose Cyclophosphamide Given Daily for
Children with Recurrent or Progressive Brain Tumors
|
|
Baltimore, MD USA |
|
11/21/2005 |
|
|
|
Details |
|
Tamoxifen and Bortezomib in Treating Patients With Recurrent Gliomas
|
|
Bethesda, MD USA |
|
11/13/2005 |
|
|
|
|
|
Details |
|
Natural History of Patients with Brain and Spinal Cord Tumors |
|
Bethesda, MD USA |
|
11/13/2005 |
|
|
|
Details |
|
FR901228 in Treating Patients With Recurrent High-Grade Gliomas |
|
Bethesda, MD USA |
|
11/13/2005 |
|
|
|
|
|
Details |
|
FR901228 in Treating Patients With Recurrent High-Grade Gliomas |
|
Bethesda, MD USA |
|
11/13/2005 |
|
|
|
Details |
|
GW572016 to Treat Recurrent Malignant Brain Tumors |
|
Bethesda, MD USA |
|
11/13/2005 |
|
|
|
|
|
Details |
|
Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma
|
|
Baltimore, MD USA |
|
11/11/2005 |
|
|
|
Details |
|
FR901228 in Treating Children with Refractory or Recurrent Solid Tumors or Leukemia |
|
Bethesda, MD USA |
|
11/11/2005 |
|
|
|
|
|
Details |
|
VNP40101M in Treating Young Patients With Recurrent, Progressive, or Refractory Primary Brain Tumors |
|
Bethesda, MD USA |
|
11/11/2005 |
|
|
|
Details |
|
Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors |
|
Bethesda, MD USA |
|
11/11/2005 |
|
|
|
|
|
Details |
|
Surgery Versus Radiosurgery to Treat Metastatic Brain Tumors |
|
Bethesda, MD USA |
|
11/11/2005 |
|
|
|
Details |
|
A Phase I Gliadel and Escalating Doses of Intravenous O6-Benzylguanine Trial in Patients with Recurrent Malignant Glioma |
|
Baltimore, MD USA |
|
11/09/2005 |
|
|
|
|
|
Details |
|
Phase I Study of Tipifarnib and Radiotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma |
|
Bethesda, MD USA |
|
11/06/2005 |
|
|
|
Details |
|
An Open-label, Dose Confirmation and Dosimetry Study of Interstitial 131I-chTNT-1/B MAB (COTARA) for the Treatment of Glioblastoma Multiforme (GBM) at 1st of 2nd Relapse |
|
Baltimore, MD USA |
|
11/06/2005 |
|
|
|
|
|
